Background: To track the European spread of SARS-CoV-2, decentralized testing became necessary and test capacity needed to be expanded outside reference laboratories rapidly. Methods: We assessed via an online questionnaire the preparedness of European hospital laboratories for detection of SARS-CoV-2 and listed the main drawbacks for implementation. Results: Forty-five percent of the surveyed labs had a test in place by March 26th which is well into the first wave of the pandemic in most countries. Conclusions: The main implementation barriers for introduction of a SARSCoV-2 molecular assay in European diagnostic laboratories were availability of positive controls and a specificity panel.

Additional Metadata
Keywords COVID, Molecular test, Pandemic, SARS-CoV-2
Persistent URL dx.doi.org/10.1016/j.jcv.2020.104432, hdl.handle.net/1765/126971
Journal Journal of Clinical Virology
Citation
Matheeussen, V. (Veerle), Loens, K. (Katherine), Lammens, C. (Christine), Vilken, T. (Tuba), Koopmans, M.P.G, D.V.M., Goossens, H, & Ieven, M. (2020). Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020. Journal of Clinical Virology, 128. doi:10.1016/j.jcv.2020.104432